References
- 보건복지부 증앙암등록본부 2022년 12월 발표자료
- 대한의학회. 대장암진료권고안v1.0. 2012.
- Wiggers T, de Vries MR, Veeze-Kuypers B. Surgery for loal recurrence of rectal carcinoma. Dis Colon Rectum 1996 Mar;39(3):323-8. https://doi.org/10.1007/BF02049476
- Gray R, Barnwell J, McConkey C, Hills RK, Williams NS, Kerr DJ. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomized study. Lancet 2007 Dec 15;370(9604):2020-9. https://doi.org/10.1016/S0140-6736(07)61866-2
- Bang SH, Son CG. A Clinical Observation of Oriental Medicine-Based Long care for terminal Rectal Cancer Patient with Multiple Metastasis. Korean J Oreien int Med 2008 Sep;29(3):567-73.
- Garaci E, Pica F, Matteucci C, Gaziano R, D'Agostini C, Miele MT, et al. Historical review on thymosin α1 in oncology: preclinical and clinical experiences. Expert Opin Biol Ther 2015;15(Suppl 1):S31-9. https://doi.org/10.1517/14712598.2015.1017466
- Fritz H, Flower G, Weeks L, Cooley K, Callachan M, McGowan J, et al. Intravenous Vitamin C and cancer: A Systemic review. Intergr cancer Ther 2014 Jul;13(4):280-300. https://doi.org/10.1177/1534735414534463
- Kienle GS, Kiene H. Complementary cancer therapy: a systematic review of prospective clinical trials on anthroposophic mistletoe extracts. Eur J Med Res 2007;12(3):103-19.
- 赵昌风, 彭磷基, 张子丽, 等. 针灸对结肠癌 肝转移患者外周T淋巴细 胞亚群NK细 胞活性的影响[J]. 中国针灸 2010;30(1):10-2.
- Hosseinzade A, Sadeghi O, Naghdipour Biregani A, Soukhtehzari S, Brandt GS, Esmaillzadeh A. Immunomodulatory Effects of Flavonoids: Possible Induction of T CD4+ Regulatory Cells Through Suppression of mTOR Pathway Signaling Activity. Front Immunol 2019 Jan;10:51.
- Dai D, Zhang CF, Williams S, Yuan CS, Wang CZ. Ginseng on Cancer: Potential Role in Modulating Inflammation-mediated Angiogenesis. Am J Chin Med 2017;45(1):13-22. https://doi.org/10.1142/S0192415X17500021
- Staib L, Link KH, Beger HG. Follow up in colorectal cancer: cost-effectiveness analysis of established and novel concepts. Langenbecks Arch Surg 2000;385(6):412-20. https://doi.org/10.1007/s004230000144
- Kim NK, Park JK, Kang YL, Seong HY, Seung KS, Jin SM. Prognostic Factors Influencing the Recurrence Pattern and Survival Rates in Curatively Resected Colorectal Cancer. J Korean Surg Soc 2002;62(5):421-9.
- Wong CS, Cummings BJ, Keane TJ, Dobrowsky W, O'Sullivan B, Catton CN. Combined radiation therapy, Mitomycin C, and 5-fluorouracil for locally recurrent rectal carcinoma. Results of a pilot study. Int J Radiat Oncol Biol Phys 1991;21(5):1291-6. https://doi.org/10.1016/0360-3016(91)90288-F
- Wong CS, Cummings BJ, Brierley JD, Catton CN, McLean M, Catton P, et al. Treatment of locally recurrent rectal carcinoma-Results and Prognostic factors. Int J Radiat Oncol Biol Phys 1998;40(2):427-35. https://doi.org/10.1016/S0360-3016(97)00737-2
- Hocht S, Hammad R, Thiel HJ, Wiegel T, Siegmann A, Wilner J, et al. Recurrent rectal cancer within the pelvis: a multicenter analysis of 123 patients and recommendations for adjuvant radiotherapy. Strahlenther Onkol 2004;180(1):15-20. https://doi.org/10.1007/s00066-004-1130-8